Astellas Venture Management Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 6
- Investments
- 84
- Portfolio
- 21
- Exits
- 43
Astellas Venture Management General Information
Description
Founded in 1999, Astellas Venture Management is the corporate venture arm of Astellas Pharma and is headquartered in Menlo Park, California. The firm makes investment in privately owned early-stage biotechnology company focused on therapeutics programs and platform technologies for drug discovery and development.
Contact Information
Website
Year Founded
1999
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 2000 Sierra Point Parkway
- Suite 500
- Menlo Park, CA 94005
- United States
Astellas Venture Management Investments & Acquisitions (84)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Catamaran Bio | 23-Nov-2020 | Early Stage VC | 0000 | Drug Discovery | Startup | |
| 0000 00000000000 | 29-Oct-2020 | 000000000000 | 00000 | Monitoring Equipment | Generating Revenue | |
| 000 | 07-Sep-2020 | 00000 00000 | 0000 | Discovery Tools (Healthcare) | Generating Revenue | |
| 00000 000000000000 | 09-Jan-2020 | 00000 00000 | 0000 | Drug Delivery | Generating Revenue | |
| 0000000 | 20-Dec-2019 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | |
| 000000000 | 22-Nov-2019 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 0000 0000000000000 | 05-Nov-2019 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 0000000000 000000000 00.0 |
| 000000 00000000000 | 17-Jun-2019 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | |
| eFFECTOR Therapeutics | 13-May-2019 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue | |
| Twentyeight-Seven | 09-May-2019 | Early Stage VC | 000.00 | Biotechnology | Generating Revenue |
Astellas Venture Management Exits (43)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Tacurion Pharma | 05-Oct-2020 | Out of Business | |
| 0000000 | 02-Oct-2020 | 000 | 0000 |
| 00000000 000000000 | 01-Oct-2019 | 000 00 00000000 | |
| 000000 000 | 11-Sep-2019 | 000000000000000000 | |
| 0000000 0000000000 | 23-May-2019 | 000 | 000.00 |
| 0000000 0000000000 | 14-Dec-2018 | 000000000000000000 | 00000 |
| 00000000 | 18-Oct-2018 | 000 | 0000 |
| 0000000000 | 28-Feb-2018 | 0000000000: 000000 | |
| Mitobridge | 23-Jan-2018 | Merger/Acquisition | 00000 |
| Viamet Group | 03-Jan-2018 | Buyout/LBO |
Astellas Venture Management Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialAstellas Venture Management Team (22)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Kazunori Maruyama Ph.D | President | 0 | Menlo Park, CA | ||
| Hiromichi Kimura Ph.D | Investment Director | Menlo Park, CA | |||
| Satoshi Konagai | Senior Investment Manager | Menlo Park, CA | |||
| Tadayoshi Hirata | Senior Investment Manager | Menlo Park, CA | |||
| Hikaru Saito Ph.D | Senior Investment Manager | Menlo Park, CA |
Astellas Venture Management Co-Investors (68)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| MPM Capital | 4 | 0 |
|
|
|
| Novartis Venture Fund | 0 | 0 |
|
|
|
| Osage University Partners | 0 |
|
|
||
| Abingworth Management | 0 | 0 |
|
|
|
| SV Health Investors | 0 | 0 |
|
|